LIPO-PAM Trademark

Trademark Overview


On Wednesday, June 23, 2021, a trademark application was filed for LIPO-PAM with the United States Patent and Trademark Office. The USPTO has given the LIPO-PAM trademark a serial number of 79317592. The federal status of this trademark filing is REGISTERED as of Tuesday, March 7, 2023. This trademark is owned by CHA Vaccine Research Institute Co., Ltd. The LIPO-PAM trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for cattle; oral vaccine preparations; veterinary vaccines; viral vaccines; vaccines; adjuvants for use with vaccines; vaccine preparations; Veterinary substances and preparations for treating and preventing viruses and other infectious diseases, inflammatory diseases, genetic diseases, neurological diseases, autoimmune diseases and cancer; human vaccine preparations; anti-microbial preparations for treating and preventing viruses and other infectious diseases; pharmaceutical preparations for treating and preventing viruses and other infectious diseases, inflammatory diseases, genetic diseases, neurological diseases, autoimmune diseases, and cancer; pharmaceutical compositions for the treatment and prevention of viruses and other infectious diseases, inflammatory diseases, genetic diseases, neurological diseases, autoimmune diseases, and cancer; reagents for medical use; diagnostic reagents for medical use for immunization diseases; diagnostic reagents for medical or veterinar...
lipo-pam

General Information


Serial Number79317592
Word MarkLIPO-PAM
Filing DateWednesday, June 23, 2021
Status700 - REGISTERED
Status DateTuesday, March 7, 2023
Registration Number6993671
Registration DateTuesday, March 7, 2023
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, December 20, 2022

Trademark Statements


Description of MarkThe mark consists of the wording "LIPO-PAM" in black stylized font.
Description of the Colors ClaimedThe color black appears in the word "LIPO-PAM".
Goods and ServicesVaccines for cattle; oral vaccine preparations; veterinary vaccines; viral vaccines; vaccines; adjuvants for use with vaccines; vaccine preparations; Veterinary substances and preparations for treating and preventing viruses and other infectious diseases, inflammatory diseases, genetic diseases, neurological diseases, autoimmune diseases and cancer; human vaccine preparations; anti-microbial preparations for treating and preventing viruses and other infectious diseases; pharmaceutical preparations for treating and preventing viruses and other infectious diseases, inflammatory diseases, genetic diseases, neurological diseases, autoimmune diseases, and cancer; pharmaceutical compositions for the treatment and prevention of viruses and other infectious diseases, inflammatory diseases, genetic diseases, neurological diseases, autoimmune diseases, and cancer; reagents for medical use; diagnostic reagents for medical use for immunization diseases; diagnostic reagents for medical or veterinary purposes; clinical diagnostic reagents for medical use; preparations of microorganisms for medical or veterinary use; hepatitis vaccine; preparations for treatment of hepatitis; vaccines against flu; immunostimulants; immunomodulators; pharmaceutical preparations for the prevention of disorders of the immune system; pharmaceutical preparations for the prevention of diseases of the immune system; pharmaceutical preparations for regulating the immune system; pharmaceutical products for the treatment of viral diseases; veterinary vaccines for bovine animals; veterinary vaccines for sheep; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical products for the treatment of cancer; drug delivery agents in the form of aqueous particles that provide a controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of injectable, inhalable, intranasal, oral, sublingual, transdermal and topical compositions that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the prevention of autoimmune disorders; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for the treatment of immune system related diseases and disorders; anti-infectives; anti-viral agents; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the treatment of tumours; biopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; compounds for treating cancer; pharmaceutical preparations and substances for the prevention of cancer
Indication of Colors claimedThe color black is claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 13, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCHA Vaccine Research Institute Co., Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressKR

Party NameCHA Vaccine Research Institute Co., Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressKR

Party NameCHA Vaccine Research Institute Co., Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressKR

Trademark Events


Event DateEvent Description
Monday, July 3, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, June 8, 2023FINAL DISPOSITION NOTICE SENT TO IB
Thursday, June 8, 2023FINAL DISPOSITION PROCESSED
Wednesday, June 7, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 7, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, March 7, 2023REGISTERED-PRINCIPAL REGISTER
Monday, February 6, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, January 18, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 18, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, December 21, 2022NOTIFICATION PROCESSED BY IB
Tuesday, December 20, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 20, 2022PUBLISHED FOR OPPOSITION
Wednesday, November 30, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 30, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 30, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 16, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 26, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 25, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 25, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 24, 2022REFUSAL PROCESSED BY IB
Monday, May 2, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, May 2, 2022REFUSAL PROCESSED BY MPU
Monday, March 21, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sunday, March 20, 2022NON-FINAL ACTION WRITTEN
Tuesday, March 15, 2022ASSIGNED TO EXAMINER
Tuesday, August 17, 2021APPLICATION FILING RECEIPT MAILED
Friday, August 13, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 12, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB